| 000 | 02562 a2200865 4500 | ||
|---|---|---|---|
| 005 | 20250517144436.0 | ||
| 264 | 0 | _c20171107 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkx042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAssoumou, L | |
| 245 | 0 | 0 |
_aPrevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _c06 2017 |
||
| 300 |
_a1769-1773 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aGenes, Viral |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 |
_aHIV Integrase _xblood |
| 650 | 0 | 4 |
_aHIV Protease _xblood |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xblood |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aCharpentier, C | |
| 700 | 1 | _aRecordon-Pinson, P | |
| 700 | 1 | _aGrudé, M | |
| 700 | 1 | _aPallier, C | |
| 700 | 1 | _aMorand-Joubert, L | |
| 700 | 1 | _aFafi-Kremer, S | |
| 700 | 1 | _aKrivine, A | |
| 700 | 1 | _aMontes, B | |
| 700 | 1 | _aFerré, V | |
| 700 | 1 | _aBouvier-Alias, M | |
| 700 | 1 | _aPlantier, J-C | |
| 700 | 1 | _aIzopet, J | |
| 700 | 1 | _aTrabaud, M-A | |
| 700 | 1 | _aYerly, S | |
| 700 | 1 | _aDufayard, J | |
| 700 | 1 | _aAlloui, C | |
| 700 | 1 | _aCourdavault, L | |
| 700 | 1 | _aLe Guillou-Guillemette, H | |
| 700 | 1 | _aMaillard, A | |
| 700 | 1 | _aAmiel, C | |
| 700 | 1 | _aVabret, A | |
| 700 | 1 | _aRoussel, C | |
| 700 | 1 | _aVallet, S | |
| 700 | 1 | _aGuinard, J | |
| 700 | 1 | _aMirand, A | |
| 700 | 1 | _aBeby-Defaux, A | |
| 700 | 1 | _aBarin, F | |
| 700 | 1 | _aAllardet-Servent, A | |
| 700 | 1 | _aAit-Namane, R | |
| 700 | 1 | _aWirden, M | |
| 700 | 1 | _aDelaugerre, C | |
| 700 | 1 | _aCalvez, V | |
| 700 | 1 | _aChaix, M-L | |
| 700 | 1 | _aDescamps, D | |
| 700 | 1 | _aReigadas, S | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 72 _gno. 6 _gp. 1769-1773 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkx042 _zAvailable from publisher's website |
| 999 |
_c27006657 _d27006657 |
||